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CX3CR1In the healthy adult brain microglia, the main immune-competent cells of the CNS, have a distinct (so-called
resting or surveying) phenotype. Resting microglia can only be studied in vivo since any isolation of brain
tissue inevitably triggers microglial activation. Here we used in vivo two-photon imaging to obtain a ﬁrst
insight into Ca2+ signaling in resting cortical microglia. The majority (80%) of microglial cells showed no
spontaneous Ca2+ transients at rest and in conditions of strong neuronal activity. However, they reliably
responded with large, generalized Ca2+ transients to damage of an individual neuron. These damage-induced
responses had a short latency (0.4–4 s) and were localized to the immediate vicinity of the damaged neuron
(b50 μm cell body-to-cell body distance). They were occluded by the application of ATPγS as well as UDP and
2-MeSADP, the agonists of metabotropic P2Y receptors, and they required Ca2+ release from the intracellular
Ca2+ stores. Thus, our in vivo data suggest that microglial Ca2+ signals occur mostly under pathological
conditions and identify a Ca2+ store-operated signal, which represents a very sensitive, rapid, and highly
localized response of microglial cells to brain damage. This article is part of a Special Issue entitled: 11th
European Symposium on Calcium.opean Symposium on Calcium.
x: +49 7071 29 5395.
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Microglia are the resident immune cells of the CNS. They play a
critical role in defending the structural and functional integrity of the
central nervous system [1,2]. In turn, the CNS microenvironment
critically impacts on phenotype of resting microglia [2]. In the healthy
adult brain, these cells have a small cell body with several long, highly
ramiﬁed processes, which are used for an active screening/palpation
of their immediate neighborhood [3,4]. Because of this ability to
actively survey their microenvironment, the microglia in the healthy
CNS are often referred to as surveillant microglia. The phenotype of
surveillant microglia is often termed “downregulated” because of a
limited number of expressed surface molecules as well as their low
expression levels [2]. An appearance of a pathological agent/event
rapidly initiates a process of microglial activation. When activated,
microglia change their morphology, upregulate a number of surface
molecules, start secreting inﬂammatory mediators, and, ﬁnally,
acquire the features of cytotoxic, phagocytic cells [1,5,6].
Microglia strongly rely in their function on intracellular calcium
signaling. In vitro data have identiﬁed more than twenty ligands of
various ionotropic andmetabotropic receptors able to evoke receptor-
mediated Ca2+ signals in microglia (reviewed in [7,8]). In addition,
increases in the intracellular free Ca2+ concentration ([Ca2+]i) can be
induced by activation of store-operated Ca2+ channels [8–11] or byNa+/Ca2+ exchangers operating in a reverse mode [12]. In vitro studies
have suggested that elevations of [Ca2+]i play a central role in the
process ofmicroglial activation (for a review, see [6,8,13,14]). SuchCa2+
elevations can be evoked by (i) lipopolysaccharides (endotoxins of the
gram-negative bacteria [15]), (ii) purines and pyrimidines, as well as
(iii) glutamate and (iv) the chemokine fractalkine released from injured
cells (reviewed in [6,10,14,16,17]), (v) amyloidogenic substances
accumulating in the brain in the course of a neurodegenerative disease
(e.g., amyloid β [18,19]), etc. These receptor-mediated Ca2+ signals
were shownto control executive functionsof activatedmicroglia suchas
release of trophic factors, NO as well as proinﬂammatory cytokines and
chemokines [1,6,8,14,15].
It remains, however, unclear to what extent the data obtained in
reduced preparations (cell cultures (see above)) and brain slices [20])
reﬂect the properties of surveillant microglia under normal physio-
logical conditions. In ex vivo preparations, microglia almost invariably
appear at different stages of activation, characteristic of pathology.
This is because the isolation of brain tissue is accompanied by a tissue
damage, which releases a host of substances triggering microglial
activation. Furthermore, cell culture procedures often utilize the
tissue from early neonatal brain, where invading microglia are still
amoeboid and have not yet been transformed into a differentiated
form found in the mature CNS [8,21,22]. Therefore, the mechanisms
underlying Ca2+ signaling in adult surveillant microglia remained
largely unknown.
Here we combined in vivo two-photon imaging with several cell-
labeling techniques to monitor intracellular Ca2+ levels in cortical
microglia. Our data show that surveillant microglia rarely generate
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neuronal activity but utilize Ca2+ release from the intracellular Ca2+
stores to signal a focal destruction of a single cell in its vicinity.
2. Materials and methods
All experimental procedures were performed in accordance with
institutional animal welfare guidelines and were approved by the
government of Baden-Württemberg, Germany.
2.1. In vivo two-photon imaging
Cells in the cortical layers 1–3 (80–160 μm below the cortical
surface) were imaged by means of two-photon microscopy in
heterozygous CX3CR1GFP/+, homozygous CX3CR1GFP/GFP, and wild-
type (C57BL/6) mice. Surgery was performed as described in Refs.
[23,24]. Brieﬂy, the mice were placed onto a warming plate (38 °C)
and anesthetized by inhalation of 1.5% isoﬂurane (Curamed, Karls-
ruhe, Germany) in pure O2. The depth of anesthesia was assessed by
monitoring the tail-pinch reﬂex and respiration rate. After removing
the skin, the skull was gently thinned under a dissecting microscope
using dental drills. The custom-made recording chamber with a hole
in the middle [24] was then glued to the skull with cyanoacrylic glue
(UHU, Buhl-Baden, Germany). The mouse was transferred to the
setup, placed onto awarming plate (38 °C), and continuously supplied
with 0.8–1.2% isoﬂurane in pure O2. If necessary, the concentration of
isoﬂurane was adjusted in the course of an experiment in order to
keep a rather superﬁcial level of anesthesia (respiration rates between
90 and 120 breaths per minute [25,26]). The recording chamber was
perfused with warm (37 °C) extracellular perfusion saline containing
(in mM) 125 NaCl, 4.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2,
1 MgCl2, 20 glucose, pH 7.4, when bubbled with 95% O2 and 5% CO2.
A craniotomy (~1 mm) was performed above an area devoid of big
blood vessels using a thin (30 G) syringe needle.
Two-photon imaging was performed with a custom-built two-
photon laser-scanning microscope based on a mode-locked laser
operating at 690- to 1040-nm wavelength (MaiTai HP DeepSee,
Spectra Physics, Mountain View, CA) and a laser-scanning system
(Olympus Fluoview 1000, Olympus, Tokyo, Japan) coupled to an
upright microscope (BX61WI, Olympus, Tokyo, Japan) and equipped
with a water-immersion objective (40×, 0.80 NA or 60×, 1.0 NA,
Nikon, Tokyo, Japan). Enhanced green ﬂuorescent protein (GFP) was
excited at a wavelength of 930 nm, whereas Oregon green BAPTA 1
(OGB-1), Fluo-4, and Alexa Fluor 594 (AF 594) were excited at
800 nm. To separate the GFP ﬂuorescence, we used excitation splitting
making use of the fact that GFP is very efﬁciently excited at 930 nm
but not at 800 nm [27]. The emitted light was further separated using
a beamsplitter either at 515 nm (to separate GFP from the other dyes)
or at 570 nm (to separate all dyes from AF 594). Most images were
collected at a sampling rate of 4 frames/s. For simultaneous imaging of
microglia, astrocytes, and neurons (e.g., Fig. 2C), a sampling rate of 10
frames/s was used. For determination of rise times and latency of
microglial calcium transients caused by cell damage, the sampling rate
was further increased to 20 frames/s. Unless otherwise indicated, all
images shown are maximum intensity projections of ±3–5 μm, taken
with a 1-μm step. Themicrophotographs shown in Figs. 1D, 3C, and 5C
represent single-plane images.
Neurons and astrocytes were stained either with OGB-1 (e.g.,
Fig. 2C) or with Fluo-4 (e.g., Fig. 2A, both from Molecular Probes,
USA) using multi-cell bolus loading technique (MCBL [23]). Brieﬂy,
the dyes (in the AM (acetoxymethylester) form) were dissolved in
DMSO containing 20% Pluronic F-127 (w/v) to a concentration of
10 mM. The injection pipette was pulled using a standard protocol
for patch-clamp electrodes (tip diameter 1 μm) and ﬁlled with the
standard pipette solution of the following composition (in mM):
150 NaCl, 2.5 KCl, and 10 HEPES, pH 7.4, supplemented with0.5 mM of Ca2+ indicator dye. The pipette was placed over the
craniotomy and inserted into the brain. When the pipette reached
the desired depth of 200 μm, the dye was pressure-ejected into the
brain by applying a positive pressure (60 kPa for 2 min). Following
dye ejection, the pipette was removed and the experiment
commenced about half an hour later. Under these experimental
conditions, Fluo-4 predominantly accumulated in astrocytes leaving
neurons virtually unstained (see also Refs. [28,29]). In contrast,
OGB-1 provided good staining of both neurons and astrocytes
[24,30]. In such preparations, astrocytes were identiﬁed by their
bright appearance [23,30], as well as their cell-type-speciﬁc
morphology [24].
2.2. In vivo staining of microglia with isolectin B4
The isolectin B4 (IB4) from Griffonia simplicifolia seeds has been
described as a microglial marker in situ [31,32]. For in vivo labeling
of microglia with IB4, we slightly modiﬁed the MCBL protocol. We
used Isolectin B4 conjugated to Alexa Fluor 594 (Molecular Probes,
USA). To prepare the stock solution, we diluted the dye to a
concentration of 500 μg/ml in the standard pipette solution (see
above) supplemented with 0.1 mM CaCl2. Frozen aliquots of the
stock solution were stored at −20 °C. Immediately before staining,
the stock solution was further diluted in the standard pipette
solution to gain the ﬁnal isolectin B4 concentration of 75 μg/ml. This
solution was then injected (duration of application: 1.5 min;
application pressure: 60 kPa) 200 μm under the cortical surface.
This protocol allowed visualization of microglial cells (e.g., Fig. 1B)
up to a depth of 300 μm. Besides microglia, Isolectin B4 also labeled
endothelial cells of blood vessels, but these long tubular structures
were easily distinguished from the microglia (see Fig. 1B).
2.3. In vivo labeling of microglia using single-cell electroporation
technique
Microglial cells were stained with OGB-1 hexapotassium salt
(Molecular Probes, USA) by means of single-cell electroporation [33].
Brieﬂy, an electroporation pipette (tip diameter b1 μm) was ﬁlled
with 10 mM OGB-1 dissolved in a solution containing (in mM) 140 K-
Gluconate, 14 KCl, 4 NaCl, and 10 HEPES, pH 7.3. A GFP- or AF594-
conjugated IB4-labeled microglial cell was targeted by the pipette. As
soon as the pipette touched the microglial cell membrane, a negative
current of 600 nA was applied for 10 ms using a MVCS-C-01
iontophoresis system (NPI Electronic, Tamm, Germany). After stain-
ing, the pipette was immediately withdrawn. Please note that this
electroporation protocol is more gentle than those applied in vivo to
electroporate neurons [33–36]. It allowed clear visualization of all
microglial cell somata. Sometimes, however, the OGB-1 signal was too
faint to enable visualization of tiny distal processes.
2.4. Drug application
Following pharmacological substances were used in this study:
ATP, ATPγS (Adenosine 5′-O-(3-thiotriphosphate)), α-β-MeATP
(α,β-methylene-ATP), Bz-ATP (Benzoylbenzoyl-ATP), 2-MeSATP (2-
methylthioATP), 2-MeSADP (2-methylthioADP), UDP (Uridine 5′-
diphosphate), carbachol, oxotremorine, glutamate, suramin, RB-2
(reactive blue 2), PPADS (pyridoxal-5′-phosphate-6-azophenyl-2′,4′-
disulfonic acid), bicuculline (all obtained from Sigma-Aldrich, St.
Louis, MO, USA); trans-ACPD ((±)-1-aminocyclopentane-trans-1,3-
dicarboxylic acid), thapsigargin (obtained from Tocris, Bristol, United
Kingdom); Fractalkine (Recombinant Mouse CX3CL1 Chemokine
Domain, obtained from R&D systems, Minneapolis, MN, USA); KCl
(solution contained (in mM): 80 KCl, 50 NaCl, 1.25 NaH2PO4, 26
NaHCO3, 2 CaCl, 1 MgCl, pH 7.4 when bubbled continuously with 95%
O2 and 5% CO2).
Fig. 1. In vivo calcium imaging of microglial cells. (A) In vivo labeling of microglial cells with Ca2+ indicator dye OGB-1. Left: a micrograph of GFP-positive microglial cells in a
CX3CR1
GFP/+ mouse. Middle: the upper microglial cell is stained with OGB-1 using a single-cell electroporation technique (electroporation pulse: 10 ms, −600 nA). Schematic
drawing indicates the position of electroporation pipette ﬁlled with 10 mM OGB-1. Right: an overlay of the left and the middle images. (B) Left: an image of microglial cells in a
CX3CR1
+/GFP mouse. GFP ﬂuorescence is excited at 930 nm, emitted light is sampled between 420 and 515 nm. Middle: the same cells imaged after staining with Alexa Fluor 594-
conjugated Isolectin B4 using MCBL (excited at 800 nm, emitted light is sampled between 515 and 725 nm). Right: an overlay of the two images. Note that isolectin B4 stains blood
vessels (arrows) in addition to microglia. Microphotographs shown in panels A and B represent maximum intensity projections of image stacks (± 10 μm, step 1 μm). (C) Somatic
microglial Ca2+ transients in CX3CR1 (top) and wild-type (bottom) mice evoked by 5 mMATP (applied locally by pressure injection, 50 ms, 20 kPa). (D) ATP-evoked Ca2+ transients
recorded in the soma and in the processes of a microglial cell. The corresponding regions of interest (ROIs) are marked with respective numbers on the left panel.
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the extracellular saline perfusing the chamber attached to the
mouse's skull [24,37]) or locally (by pressure ejection, using a
pressure-ejection system from NPI Electronic, Tamm, Germany)
directly to the cells of interest. Locally applied drugs weredissolved (except of fractalkine) in the standard pipette solution
(see above). The chemokine domain of fractalkine was dissolved
in PBS containing 0.1% bovine serum albumin (both obtained
from Invitrogen GmbH, Karlsruhe, Germany) to a ﬁnal concen-
tration of 250 μg/ml.
Fig. 2. Spontaneous calcium signals in microglia. (A) Continuous recordings of [Ca2+]i (right) in astrocytes (black traces) and microglia (red traces), marked with respective
numbers in the left panel. GFP-positive microglial cells (red) were labeled with OGB-1 (green) and therefore appear yellow. Astrocytes were stained with Fluo-4 (green) using
MCBL. Asterisk indicates an intercellular astrocytic Ca2+ wave. (B) A bar graph illustrating the fraction of cells showing a spontaneous Ca2+ transient during a 15-min-long
recording period. (C) Simultaneous recordings of [Ca2+]i in the microglia (red trace), and in layer 2/3 cortical neurons (black traces) during a period of increased neuronal
activity caused by a topical application of the GABAA receptor antagonist bicuculline (250 μm). The corresponding cells are marked with the respective numbers in the left
panel. The GFP-positive microglial cell (red) was stained with OGB-1 (green) via electroporation and therefore appears yellow. Neurons and astrocytes were loaded with OGB-1
using MCBL and discriminated based on their characteristic shape and on the brightness of their staining [23]. (D) A bar graph showing the fraction of cells active during
bicuculline application.
1017G. Eichhoff et al. / Biochimica et Biophysica Acta 1813 (2011) 1014–1024To allow visualization of the drug application pipette and to
improve the precision of the pipette positioning, 50 μM of the cell-
impermeant, red ﬂuorescent dye Alexa Fluor 594 (AF 594,
Molecular Probes, Eugene, Oregon, USA) was added to the drug-
containing solution in some experiments. The application pipette
(tip diameter 1 μm) was placed under the visual control 30 to
40 μm away from the microglial cell of interest and a pressure
pulse of 20–35 kPa was applied for 50 ms. Successful drug
application was ascertained either by ﬂuorescence of AF 594 or
by the small (~1–3 μm) movement artifact caused by the pressure
application (e.g., Fig. 5C).
The blockers of P2-purinoceptors (suramin, RB-2, PPADS) were
pressure applied directly to the recorded microglial cell at
continuous pressure of 4 kPa. Application started at least 1 min
before damaging a neuron (see below). Prolonged application of
some blockers (e.g., RB-2) resulted in darkening of the recorded
area and disappearance of microglial processes. Therefore, we did
not increase the blocker's concentration further. A similar protocol
was used in occlusion experiments (e.g., Fig. 5A and B) for the
application of ATPγS, UDP and 2-MeSADP. Finally, thapsigargin
(25 μM) was also applied directly to the microglial cell of interest
by ﬁve repetitive pressure pulses (50 ms, 35 kPa). Bicuculline
(250 μM) was applied topically for 20 min preceding the recordingsand was present in the extracellular saline throughout the
experiment.
2.5. Cell damaging procedure
A micropipette was ﬁlled with the extracellular perfusion saline
(see above) supplemented with 500 μM of Alexa Fluor 594 (the
resistance of the ﬁlled pipette: 6–7 MOhm). Thereafter, the pipette
was positioned into the layer 2/3 at a desired distance from the
microglial cell of interest within the same imaging plane. A minimal
positive pressure was applied to the pipette to release small amount
of AF 594 into the extracellular space. This procedure allowed
visualizing the soma of a nearby cortical layer 2/3 neuron as a
negative image [36]. Thereafter, the cell-damaging pipette was
positioned at the cell membrane and rapidly moved forward by
10 μm in a step-like fashion while imaging the microglial cell. Upon
the rupture of the cell membrane, the resistance of the micropipette
(continuously monitored with MVCS-C-01 M-45 unit; NPI electronic,
Tamm, Germany) dropped from approximately 12–13 MOhm (when
touching the cell membrane) back to 6–7 MOhm and Alexa Fluor
594 diffused into the neuron (e.g., Fig. 3A). The time point of
neuronal damage was estimated either from an increase in the
ﬂuorescence within a region of interest positioned inside the
Fig. 3. Neuronal damage causes rapid Ca2+ signals in microglial cells. (A) Maximum intensity projections (±15 μm) taken 2 min before (left) and 4 min after (right) the cell
damaging procedure (described in detail in Materials and methods). Left: two GFP-positive microglial cells are shown in red; the left one (arrow) is stained with OGB-1
(green) and therefore appears yellow. The cell-damaging pipette ﬁlled with AF 594 (green) is touching a neuron (seen as a dark shadow, asterisk). Note that after the
rupture of the cell membrane, the neuron was immediately ﬁlled with AF 594, diffusing out of the pipette (right). (B) A recording of microglial [Ca2+]i (top) and of the
intraneuronal AF 594 ﬂuorescence (bottom). Alexa ﬂuorescence is recorded from the region of interest located within the targeted (and later damaged) neuron. The time
point of neuronal damage is identiﬁed as the time point at which Alexa ﬂuorescence starts to increase within the targeted neuron (arrowhead in B). (C) DICTs (right)
recorded from regions of interest marked with respective numbers in the left panel. The microglia is stained with OGB-1 (grayscale single-plane image) and the damaged cell
is ﬁlled with AF 594 (green). (D) Dependence of the DICT latency on the soma-to-soma distance (from the border of one cell soma to the border of the other) between the
microglia and the damaged neuron. The solid line represents the linear least squares ﬁt to the data. (E) DICT amplitudes (normalized to the amplitude of the Ca2+ transient
induced in the same cell by 5 mM ATP) plotted against the corresponding soma-to-soma distances between the microglia and the damaged cells. (F) Simultaneous recordings
of [Ca2+]i in microglia and neighboring astrocytes (located as illustrated in the inset). (G) A bar graph illustrating the fraction of microglial cells (red, n=50) and astrocytes
(gray, n=1, 8, 3, 2, total of 14 cells) responding to neuronal damage with a given latency.
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resistance. For quantitative measurements (e.g., estimating the
latencies of damage-associated Ca2+ transients, Fig. 3D), the latter,
more precise method was used. In was possible to repeat this
experiment several times by killing neurons at different distances
from the microglial cell of interest.2.6. Image analyses
Image analyses were performed off-line with the ImageJ
software (http://rsb.info.nih.gov/ij/) and Igor Pro (Wavemetrics,
Lake Oswego, Oregon, United States). Measured values are given as
mean±SEM.
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3.1. In vivo calcium imaging of microglial cells
Functional properties of resting microglia were studied in the
cortex of adult (2- to 4-month-old) mice using high-resolution in vivo
two-photon imaging. To visualize microglial cells, we ﬁrst used
heterozygous CX3CR1+/GFP mice (CX3CR1 mice [38]) in which the
CX3CR1 gene in the mutant allele is replaced by a gene coding for the
enhanced green ﬂuorescent protein (GFP). Because multi-cell bolus
loading technique (MCBL [23]) usually produces a very poor staining
of microglia (Supplementary Fig. 1), we stained microglial cells with
the Ca2+ indicator dye Oregon green BAPTA 1 (OGB-1) using a single-
cell electroporation technique (Fig. 1A, see Materials and methods for
details). In addition, we used wild-type (WT) mice in this study.
Microglia in WT mice were identiﬁed by their ability to bind a
glycoprotein isolectin B4 [31,32]. As shown in Fig. 1, an MCBL-like
injection of isolectin B4 conjugated with a red dye Alexa Fluor 594 (AF
594; see Materials and methods for details) brightly stained microglia
(and blood vessels) in CX3CR1 and WT mice. The AF 594-labeled cells
were subsequently electroporated with OGB-1 as described above.
Several lines of evidence suggested that the electroporation
protocol used did not harm the functional properties of microglial
cells. First, after electroporation, OGB-1-labeled microglia preserved
their ramiﬁed morphology for at least an hour, which was an
average duration of our recordings (Supplementary Fig. 2A; n=8
cells monitored on average for 62.5±5.6 min). Second, we analyzed
the chemotactic response [4] of labeled cells. As illustrated in
Supplementary Fig. 2B, the cells preserved the capability of directed
process extension towards the tip of an ATP-containing pipette.
Only in about 10% of cases, the entire cell turned extremely bright
immediately after electroporation and its processes became frag-
mented, indicating cell damage. These cells were excluded from
further analyses.
To compare the strength of the chemotactic response of GFP-
labeled microglia in CX3CR1 and AF 594-labeled microglia in WT
mice, we measured the diameter of the spherical containment
formed by microglial processes around the ATP-containing pipette.
Thirty minutes after the pipette insertion, the diameter amounted to
8.3±0.5 μm in WT (n=18 trials) and to 9.2±0.3 μm in CX3CR1
(n=13) mice (p=0.5, Student's t-test).
A brief pressure application of 5 mM ATP triggered large
intracellular Ca2+ transients in the OGB-1-labeled microglia in
both CX3CR1 and WT mice (Fig. 1C). These Ca2+ signals were seen
throughout an entire cell including its processes (Fig. 1D). The
kinetic properties of ATP-evoked microglial Ca2+ transients were
similar in CX3CR1 and WT mice (rise time: 0.8±0.1 s, n=10 cells in
CX3CR1 vs. 0.8±0.1 s, n=10 cells in WT mice, p=0.9, Student's t-
test; decay time constant: 5.1±0.1 s in CX3CR1 vs. 6.4±0.8 s in WT
mice, p=0.2, Student's t-test). Other stimuli (see below) also
elicited similar Ca2+ signals in both mouse strains. Therefore, in the
results presented below, the data obtained from both mouse strains
have been averaged together.
3.2. Spontaneous Ca2+ signaling in microglia
Because ATP can be released under physiological conditions (e.g.,
from axons and astrocytes [39], it may cause “spontaneous” Ca2+
transients in resting microglial cells, as was shown in vitro [40]. To
test whether this is the case in vivo, we simultaneously imaged
microglial cells and astrocytes over long periods of time (Fig. 2A). In
the course of a 15-min-long recording period, 70% of astrocytes (32/
46 cells) showed at least one spontaneous Ca2+ transient (mean
frequency 0.2±0.1 transients/min) whereas 78% of microglial cells
(21/27) remained silent. The remaining 6 cells exhibited Ca2+
transients with amplitudes of 40.4±6.0% ΔF/F, rise times of 12.4±3.7 s and decay time constants of 12.0±2.1 s (n=14 transients). In 4
out of 6 cells, more than a single Ca2+ transient was observed. The
interval between the two successive transients (from beginning of
the ﬁrst until the beginning of the second) was on average 2.3±
0.2 min (n=7 intervals).
Next we asked whether microglia participated in so-called
intercellular astrocytic Ca2+ waves (for a recent review, see [41]),
which caused correlated Ca2+ increases in surrounding astrocytes
(asterisk in Fig. 2A, right). Astrocytic Ca2+ transients were considered
to belong to the same Ca2+ wave if they occurred in all participating
cells within ±5-s time window (measured from the Ca2+ transient
with the median latency). Altogether we have analyzed 45 waves
involving two astrocytes, 19 waves involving three, 12 waves
involving four and one intercellular Ca2+ wave involving ﬁve
astrocytes. Out of these 77 waves, there was a single case when two
microglial cells were active simultaneously with 4 astrocytes (latency
from the temporally closest astrocytic Ca2+ transient to those in
microglia was 1.5 and 2 s, respectively). However, these microglial
cells did not participate in the following Ca2+ waves involving the
same astrocytes (2 waves involving 4 and 2 waves involving 3
astrocytes). The remaining microglial Ca2+ transients either occurred
completely in the absence of astrocytic activity, or had a very long
latency (0.5–1 min) to the temporally closest astrocytic Ca2+
transient, with microglial transients both preceding and following
the Ca2+ transients in astrocytes. We concluded therefore that
surveillant microglia do not participate in astrocytic Ca2+ waves.
In the next series of experiments, we topically applied GABAA
receptor antagonist bicuculline (see Materials and methods for
details) to induce strong neuronal activity and simultaneously imaged
neurons, astrocytes, and microglia. Under these conditions, 95% of
neurons showed typical synchronized Ca2+ transients with a mean
frequency of 30–40 transients per minute [42,43]. In addition, we
observed an increase in the fraction of active astrocytes (from 70 to
79%; mean frequency 0.2±0.1 transients/min). However, even in
conditions of strong neuronal activity, 79% of microglial cells
remained silent. Microglial Ca2+ transients were seen only in 3 out
of 14 recorded cells. These Ca2+ transients, however, were somewhat
larger and longer than the ones observed under control conditions
(amplitudes: 50.7±7.7% ΔF/F, rise times: 8.2±1.8 s and decay time
constants: 22.0±3.3 s (n=7 transients)). Thus, with regard to their
Ca2+ signaling, the majority of microglial cells are silent both at rest
and under conditions of strong neuronal activity.
3.3. Damage-induced microglial Ca2+ transients
Next, we tested whether microglia respond with Ca2+ signals to
damage of an individual neuron. To this end, we ﬁlled a micropipette
with Alexa Fluor 594, positioned it at the surface of a neuron, and
rapidly moved it forward by 10 μm, thereby inserting the pipette into
the cell (Fig. 3A; seeMaterials andmethods for details). To ensure that
the inserted pipette remained inside the damaged cell and therefore
never directly came into contact with microglia, we routinely made
3D reconstructions of the imaged area (Supplementary Movie). This
cell-damaging procedure reliably evoked Ca2+ transients in all
surrounding microglia (Fig. 3B; n=17 trials in n=9 cells in CX3CR1
and n=43 trials in n=19 cells in WT mice). We termed these
microglial Ca2+ signals the damage-induced Ca2+ transients or DICTs.
Importantly, no DICTs were observed when the pipette was similarly
moved forward in the surrounding neuropil without targeting a
neuron (n=15, not shown). The damage-induced Ca2+ transients
occurred both in cell bodies and in the microglial processes (Fig. 3C).
They had large amplitudes (comparable to those evoked by 5 mM
ATP, Fig. 3E) and long durations but relatively short onset latencies
(the shortest being 400 ms). The DICT latencies increased linearly
with the distance between the damaged neuron and the recorded
microglial cell, reaching some 3.5 s at a distance of 40 μm (Fig. 3D).
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unchanged over the ﬁrst 40–50 μm but rapidly decreased thereafter,
so that no DICTswere detected inmore distantmicroglia (Fig. 3E). The
existence of this sharp border suggests that DICTs are restricted to the
microglial cells immediately adjacent to the damaged neuron and that
the cell-damage-related signal does not pass to more distantly located
microglia.
If the DICTs are caused by a diffusible substance released from the
damaged neuron, this substance may also directly signal to neigh-
boring astrocytes. To test this hypothesis, we simultaneously imaged
microglia and astrocytes when damaging a neuron (Fig. 3F, G). Out of
37 astrocytes tested, only 16 cells (43%) showed a Ca2+ transient
during the recording period following the neuronal damage. To
distinguish between spontaneous (see Fig. 2A) and damage-related
astrocytic Ca2+ transients, we compared the percentage of cells activeFig. 4. Pharmacological proﬁle of microglial Ca2+ signals. (A) Here and below each cell was ﬁ
drug tested (α-β-MeATP (α,β-Methylene-ATP); 10 mM, right). (B) Representative examples
(2-methylthioADP; 500 μM, top right), Bz-ATP (Benzoylbenzoyl-ATP; 5 mM, bottom left), a
percentage of cells responding with a Ca2+ transient to application of a given agonist. From
(5 mM, n=16); Bz-ATP (5 mM, n=42);α-β-MeATP (10 mM, n=13); 2-MeSADP (500 μM, n
dicarboxylic acid; 5 mM, n=14); carbachol (10 mM, n=7)/oxotremorine (5 mM, n=7);
targeted by the respective agonists are listed within the appropriate bar. (D–F) Dose–respon
cells to increasing concentrations of ATP and UDP are shown in panels D and E, respectively
response amplitude is normalized to the maximum change in ﬂuorescence caused by applic
data using the Hill equation.during identical time intervals (i) preceding and (ii) following
neuronal damage. The results (Supplementary Fig. 3) suggest that
there is a correlation between astrocytic Ca2+ transients and neuronal
damage. However, the latencies of the astrocytic Ca2+ transients were
much longer compared to the DICT latencies and did not depend on
the distance to the damaged cell (Supplementary Fig. 3B). The average
latency of astrocytic Ca2+ transients was 34.8±3.6 s (n=16), more
than 7 times longer than that of the microglia (Fig. 3D, G;
Supplementary Fig. 3B). Taken together, these data show that only
microglia reliably respond to neuronal damage with a Ca2+ transient.
3.4. Mechanisms underlying the damage-induced Ca2+ transients
To understand the mechanisms underlying DICTs, we ﬁrst
determined the pharmacological proﬁle of microglial Ca2+ signals inrst challenged with a brief ATP application (left; 5 mM, 50 ms, 20 kPa) and then with the
of Ca2+ transients evoked by 2-MeSATP (2-methylthioATP; 5 mM, top left), 2-MeSADP
nd UDP (Uridine 5′-diphosphate; 100 μM, bottom right). (C) A bar graph showing the
left to right: ATPγS (adenosine 5′-O-(3-thiotriphosphate); 5 mM, n=12); 2-MeSATP
=51); glutamate (10 mM, n=14); trans-ACPD ((±)-1-aminocyclopentane-trans-1,3-
fractalkine (chemokine domain; 250 μg/ml, n=7) and KCl (80 mM, n=5). Receptors
se relations for two purinergic receptor agonists. Representative responses of microglial
. (F) Dose–response curves for ATP (black, n=11 cells) and UDP (red, n=11 cells). The
ation of 100 μM ATP or UDP, respectively. Solid lines represent ﬁts to respective sets of
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ATP and then with one of the agonists of purinergic, cholinergic or
glutamatergic receptors, etc. (e.g., Fig. 4A). To exclude unexpected
network effects, these experiments were conducted in the presence of
2 μM TTX in the perfusion saline. As summarized in Fig. 4C, microglia
readily responded with Ca2+ transients to agonists of P2X and P2Y
receptors, such asα-β-MeATP (α,β-Methylene-adenosine-5′-triphos-
phate), Bz-ATP (benzoylbenzoyl-ATP), UDP, etc.
ATP and UDP also evoked clear Ca2+ transients when applied at
very low concentrations (1–5 μM in the application pipette; Fig. 4D–
F). Taking into account the dilution of the drug during its diffusion in
the extracellular space (Eq. (17) in [44]), the effective concentration
reaching the cell under these conditions is estimated to be in the
submicromolar range. Such high sensitivity to ATP is unique to
surveillant microglia because cultured microglial cells do not respondFig. 5. The mechanism underlying damage-induced Ca2+ transients in microglia. (A) [Ca2+
application of 5 mM ATPγS. Note that neuronal damage fails to cause any DICTs during (lef
experiment, one during and one after the application of ATPγS. (B) The same experiment a
evoked by a brief pressure application of 100 μMUDP (top, middle, and right) and 5 mM Bz-
long pressure applications of thapsigargin. A single-plane image of the recorded cell is shown
neuronal damage (left) as well as UDP (middle) and Bz-ATP (right) applications conductedto ATP applied in the concentration lower than 10 μM [40]. Responses
with the maximal amplitude (69.22±6.77% ΔF/F, n=10) were
observed at 100 μM ATP in the application pipette (Fig. 4F).
Application of 5 mM ATP did not cause any further increase in the
response amplitude (75.26±3.12% ΔF/F, n=30; not signiﬁcantly
different from that evoked by 100 μM ATP, p=0.5, Student's t-test).
Thus, Ca2+ signaling in resting microglial cells in vivo is mediated by
purinergic receptors with high agonist sensitivity.
Next we applied glutamate to stimulate ionotropic and metabo-
tropic glutamate receptors known to be expressed by cultured
microglia [45]. The application protocol used for studying P2-
receptor-mediated signaling (e.g., drug application for 50 ms at 20–
35 kPa) caused glutamate-activated Ca2+ transients only in 14% of
cells (2/14) and failed to produce any trans-ACPD-mediated Ca2+
signals (Fig. 4C). However, using signiﬁcantly longer drug applications]i recordings from the same microglial cell during (left) and 5 min after (right) local
t) but not after (right) ATPγS application. Two different neurons were damaged in this
s in panel A using the local application of 100 μM UDP. (C) Microglial Ca2+ transients
ATP (bottom, middle, and right) before (middle) and after (right) ﬁve repetitive 50-ms-
in the left panel. (D) A continuous recording of [Ca2+]i in another microglial cell during
after the thapsigargin treatment.
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tested. A smaller fraction (29%; 2/7 cells) responded to prolonged
application of the agonist of metabotropic glutamate receptors, trans-
ACPD. Other drugs/treatments, which were shown to induce micro-
glial Ca2+ signals in vitro (e.g., cholinergic agonists [46,47], fractalkine
[48], and depolarization of the cell membrane [49]), were ineffective
(Fig. 4C). Because fractalkine is released by the damaged neuron [50]
and theoretically could trigger DICTs, we performed cell-damaging
experiments in homozygous CX3CR1GFP/GFP mice lacking the fractalk-
ine receptor. However, we observed the full-blown DICTs in these
mice, too (normalized DICT amplitude (e.g., Fig. 3E) was 0.99±0.03,
n=4). These data are consistent with the ﬁnding that the soluble
form of fractalkine fails to evoke any Ca2+ signals in microglia in vivo
(Fig. 4C) and argue against the role of fractalkine in generating DICTs.
As shown in Fig. 5A and B, DICTs were completely and reversibly
occluded by ATPγS (n=5) or UDP (n=5). Continuous applications of
ATPγS (5 mM, Fig. 5A) or UDP (100 μM, Fig. 5B) directly to the
recorded microglia (see Materials and methods for details) initially
caused elevations in [Ca2+]i themselves. These Ca2+ elevations,
however, were transient with [Ca2+]i returning to the baseline within
1–2 min. Under these conditions, neuronal damage failed to induce
any DICTs. DICTs were also occluded in the presence of another P2Y
receptor agonist, 2-MeSADP (n=6, not shown). These data suggest
that DICTs are mediated by ATP or its analogs acting on P2Y receptors.
Unfortunately, it was not possible to directly test this hypothesis
using P2Y receptor antagonists because of the lack of potent, speciﬁc
blockers. The drugs available (suramin (1 mM in the pipette, n=5),
RB-2 (reactive blue 2, 100 μM, n=5), and PPADS (pyridoxal-5′-
phosphate-6-azophenyl-2′,4′-disulfonic acid; 10 mM, n=5)) failed to
block DICTs even when applied directly to the microglial cell of
interest (seeMaterials andmethods for details), with drug application
beginning at least 1 min before damaging the neuron.
Therefore, we tested whether DICTs require Ca2+ release from the
intracellular Ca2+ stores, as would be expected for signals mediated
by P2Y receptors. To do so we locally applied thapsigargin.
Thapsigargin causes irreversible blockade of endoplasmic reticulum
Ca2+ pumps and thereby empties intracellular Ca2+ stores [51,52]. As
expected, thapsigargin application caused a complete blockade of
responses to the agonist of metabotropic P2Y6 receptors UDP,
whereas responses to Bz-ATP, preferentially activating ionotropic
P2X7 receptors, were still present (Fig. 5C, D). Under these
experimental conditions, DICTs were also completely blocked
(n=4, Fig. 5D). We concluded, therefore, that DICTs critically depend
on Ca2+ release from the intracellular Ca2+ stores.
4. Discussion
Other than morphological studies [3,4,53–56], little is known
about functional properties of differentiated (surveillant) microglia.
This is mostly due to technical difﬁculties caused by the fact that (i)
these cells have to be studied in vivo and (ii) the commonly used
technique for in vivo labeling of cells with calcium indicator dyes [23]
does not label microglia (Supplementary Fig. 1). Here we describe an
approach enabling in vivo analyses of Ca2+ signaling in differentiated
microglia. It combines in vivo labeling of the tissue with Isolectin B4
conjugated to Alexa Fluor 594 (or the use of genetically modiﬁed
animals with ﬂuorescently labeled microglia), single-cell electropora-
tion technique, and high-resolution two-photon calcium imaging and
can be used for analyses of microglial function in non-modiﬁed, wild-
type mice.
So far, our knowledge about in vivo function of microglia comes
mostly from CX3CR1mice [3,4,55]. Despite a small concern regarding a
decreased level of fractalkine receptor expression in these animals
[22], it is generally accepted that microglia in CX3CR1+/GFP mice
behave like wild-type microglia [50]. Consistently, a recent study
using Iba1-eGFP mice reported very similar kinetics of microglialprocess motility in both mouse strains [54]. The in vivo IB4-based
labeling technique introduced here allows to visualize microglia in
any deliberatemouse strain. This approach abandons time-consuming
crossing of mouse lines and thus signiﬁcantly accelerates studies in
which multiple cell types have to be ﬂuorescently labeled (e.g., [54]).
IB4 binds to α-D-galactose-containing glycoconjugates on the surface
of microglial cells [31,32] and was previously mostly used as a
postmortem histological marker. Although theoretically IB4 binding
can impact on the functional properties of labeled microglial cells, our
data suggest that this is not the case. Indeed, both eGFP- and IB4-
AF594-labeled microglial cells had (i) similar chemotactic responses,
(ii) similar kinetics of ATP-induced intracellular Ca2+ transients, and
(iii) reliably respondedwith large Ca2+ transients to a focal damage of
a nearby neuron. In addition, microglial cells in both preparations had
similar pharmacological proﬁles. Thus, the in vivo IB4-labeling
protocol introduced here seems to be a useful tool for studying
microglial function.
The approach described above enabled us to study in vivo Ca2+
signaling in differentiated surveillant microglia. Our data suggest that
under physiological conditions, differentiated microglia are rather
silent in terms of their Ca2+ signaling. Indeed, at rest ~80% of cells
tested did not show a single Ca2+ transient during a 15-min-long
recording period. Ca2+ transients in remaining cells were rare and
were not correlated with spontaneous Ca2+ waves in surrounding
astrocytes. This ﬁnding contrasts with the data obtained in rat
hippocampal cultures [40]. In culture spontaneous Ca2+ transients in
microglial cells are caused by ATP released from neighboring
astrocytes. Astrocyte-released ATP activates P2X7 receptors in micro-
glia and can even trigger microglial apoptosis [40]. Although
astrocytes generate spontaneous Ca2+ transients also in vivo
(Fig. 2A, B) and microglia are equipped with highly sensitive ATP
receptors (Fig. 4D–F), under resting conditions, astrocytic Ca2+
signals do not propagate to neighboring microglia. Interestingly, the
incidence of spontaneous Ca2+ transients in microglia remained low
even in conditions of strong neuronal activity (Fig. 2C). This led us to
conclude that somatic Ca2+ signaling is not required for surveying
function of microglia.
We hypothesized therefore that microglia undergo an increase in
[Ca2+]i not spontaneously but in response to disturbance of tissue
homeostasis. Indeed, all microglial cells studied responded with
large Ca2+ transients to focal damage of an individual neuron in
their vicinity (Fig. 3). On the level of the individual microglial cell,
this Ca2+ signal represented a generalized event. At the same time,
it was strictly localized to the cells dwelling within a 50-μm vicinity
of a damaged neuron. Interestingly, generation of rapid DICT signals
is a feature unique to microglia. Astrocytes, although also equipped
with ATP receptors [57], either did not respond to neuronal damage
at all (60% of cells) or did so with a much longer delay
(Supplementary Fig. 3).
Our data show that DICTs are caused by Ca2+ release from the
intracellular Ca2+ stores. Two lines of evidence suggest that this Ca2+
release is triggered by activation of P2Y receptors: (i) spatial and
temporal properties of DICTs are faithfully mimicked by local
application of ATP (Figs. 1D, 4E), ATPγS (Fig. 5A), and UDP (Fig. 5B)
and (ii) DICTs are occluded by ATPγS as well as agonists of
metabotropic P2Y receptors UDP and 2-MeSADP. According to our
functional data (Fig. 4) as well as receptor expression studies of others
[58,59], DICTs are most likely to be mediated by P2Y6 or P2Y1
(eventually also P2Y2/4) receptors. Unfortunately, the lack of potent
non-competitive P2Y receptor blockers precluded the direct test of
this hypothesis. The drugs available (suramin, RB-2, and PPADS) failed
to block DICTs. This failure is not surprising because none of the drugs
are a potent selective blocker of the listed above receptors [60–62]. In
addition, in vivo pharmacology has several technical caveats. To be
effective in vivo antagonists have to be applied in a concentration ~10
times higher than the one used in cell cultures or tissue slices [4,24].
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prolonged applications of high concentrations of RB-2 (≥1 mM)
destroyed surrounding tissue.
Therefore, as they stay now our data are also consistent with the
possibility that DICTs are caused by an unknown substance acting
via another type of metabotropic receptor, which in turn activates
intracellular store-mediated Ca2+ release. However, this alternative
seems less likely. Because DICTs occur very rapidly, this unknown
substance has to be released from damaged neurons at the
relatively high concentration and on the millisecond time scale.
This is true for neuronal neurotransmitters, in the cortex mostly for
glutamate. However, neither glutamate itself nor metabotropic
receptor agonist trans-ACPD were able to activate 100% of cells
tested. Other metabotropic receptor agonists (e.g., carbachol and
oxotremorine) failed to cause any Ca2+ transients at all. Interest-
ingly, although microglial cells in vivo also express functional P2X
receptors (as indicated by Bz-ATP- and α-β-MeATP-induced Ca2+
signaling, Fig. 4), the ionotropic purinoreceptors are not involved in
DICT generation.
The functional role of these long-lasting, generalized microglial
Ca2+ signals remains to be explored. DICTs occur immediately after
neuronal damage (on the millisecond-to-second scale) and thus
long before the damage-induced changes in microglial morphology
(initiated within the ﬁrst few minutes [3,4]) take place. Therefore,
DICTs most likely operate as a switch, triggering processes relevant
to microglial activation. Such processes may include (i) reorgani-
zation of actin cytoskeleton [53,63,64], (ii) CREB phosphorylation
[2,65], (iii) gene expression and de novo protein synthesis (e.g.,
production of cytokines and chemokines, cyclooxygenase-2 [1,6,65],
and BDNF [5,66]), (iv) release of pro- and/or anti-inﬂammatory
mediators [1,6,8], and (v) microglial phagocytosis [67]. The fact
that DICTs remain restricted in space suggests that single-cell
damage is treated as a local event, involving only immediately
adjacent microglia.
Taken together, our data suggest that in vivo somatic Ca2+ signaling
in microglia is not involved in the surveillance of the extracellular
milieu or in the detection of physiological levels of neuronal/astroglial
activity. Rather, it functions as highly sensitive and speciﬁc signal for
recognition of the damage in the microglial microenvironment.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2010.10.018.
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